{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:30:23Z","timestamp":1790173823475,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":1805,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1038\/modpathol.2017.135","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T07:41:58Z","timestamp":1507275718000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course"],"prefix":"10.1016","volume":"31","author":[{"given":"Zhihong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen J","family":"Schlette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken H","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyur Pravinchandra","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto N","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maitrayee","family":"Goswami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Jorgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sa A","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2017.135_bib1","unstructured":"Swerdlow SH, Campo E, Seto M et alMantle cell lymphoma. In: Swerdlow SH, Campo E, Harris NL et al eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn. France, Lyon, 2008, pp 229\u2013232."},{"key":"10.1038\/modpathol.2017.135_bib2","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3109\/10428194.2014.940584","article-title":"Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the EuropeanMantle Cell Lymphoma Network","volume":"56","author":"Dreyling","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1038\/modpathol.2017.135_bib3","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2017.135_bib4","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3324\/haematol.2011.047357","article-title":"Indolent mantle cell lymphoma","volume":"96","author":"Furtado","year":"2011","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.135_bib5","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1038\/modpathol.2017.135_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma\u2014a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2017.135_bib7","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.135_bib8","first-page":"149","article-title":"Neuronal\/lymphoid membrane glycoprotein MRC OX-2 is a member of the immunoglobulin superfamily with a light-chain-like structure","volume":"51","author":"Barclay","year":"1986","journal-title":"Biochem Soc Symp"},{"key":"10.1038\/modpathol.2017.135_bib9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2567.2001.01163.x","article-title":"The unusual distribution of the neuronal\/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans","volume":"102","author":"Wright","year":"2001","journal-title":"Immunology"},{"key":"10.1038\/modpathol.2017.135_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1309\/AJCP59UORCYZEVQO","article-title":"Diagnostic usefulness and prognostic impact of CD200 expression in lymphoid malignancies and plasma cell myeloma","volume":"137","author":"Alapat","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.135_bib11","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2009.07644.x","article-title":"CD200\/OX2, a cell surface molecule with immuno-regulatory function, is consistently expressed on hairy cell leukaemia neoplastic cells","volume":"145","author":"Brunetti","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1038\/modpathol.2017.135_bib12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2310\/JIM.0b013e31823908f9","article-title":"CD200 expression in B-cell chronic lymphoproliferative disorders","volume":"60","author":"El Desoukey","year":"2012","journal-title":"J Investig Med"},{"key":"10.1038\/modpathol.2017.135_bib13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1309\/AJCPEBK31VQQNDDR","article-title":"CD200 flow cytometric assessment and semiquantitative immunohistochemical staining distinguishes hairy cell leukemia from hairy cell leukemia-variant and other B-cell lymphoproliferative disorders","volume":"140","author":"Pillai","year":"2013","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.135_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/cytob.21128","article-title":"CD200 has an important role in the differential diagnosis of mature B-cell neoplasms by multiparameter flow cytometry","volume":"86","author":"Sandes","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1038\/modpathol.2017.135_bib15","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1189\/jlb.1009686","article-title":"The role of CD200 in immunity to B cell lymphoma","volume":"88","author":"Wong","year":"2010","journal-title":"J Leukoc Biol"},{"key":"10.1038\/modpathol.2017.135_bib16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/AJCPBV9ELXC0ECVL","article-title":"Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging","volume":"142","author":"Challagundla","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.135_bib17","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.leukres.2009.01.017","article-title":"CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia","volume":"33","author":"Palumbo","year":"2009","journal-title":"Leuk Res"},{"key":"10.1038\/modpathol.2017.135_bib18","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1158\/1078-0432.CCR-13-1077","article-title":"Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry","volume":"20","author":"Espinet","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1038\/modpathol.2017.135_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/PAS.0000000000000743","article-title":"Distinguishing between hepatosplenic T-cell lymphoma and gammadelta T-cell large granular lymphocytic leukemia: a clinicopathologic, immunophenotypic, and molecular analysis","volume":"41","author":"Yabe","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.135_bib20","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1309\/JQMR-323G-71Y9-M7MB","article-title":"Cytogenetic findings in mantle cell lymphoma cases with a high level of peripheral blood involvement have a distinct pattern of abnormalities","volume":"116","author":"Onciu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/modpathol.2017.135_bib21","series-title":"International System for Human Cytogenetic Nomenclature","author":"Shaffer","year":"2013"},{"key":"10.1038\/modpathol.2017.135_bib22","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.135_bib23","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","article-title":"Mantle cell lymphoma with MYC rearrangement: a report of 17 patients","volume":"41","author":"Hu","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2017.135_bib24","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/jclinpath-2015-202862","article-title":"LEF1: a highly specific marker for the diagnosis of chronic lymphocytic B cell leukaemia\/small lymphocytic B cell lymphoma","volume":"68","author":"Menter","year":"2015","journal-title":"J Clin Pathol"},{"key":"10.1038\/modpathol.2017.135_bib25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.anndiagpath.2016.09.016","article-title":"Expression of LEF1 in mantle cell lymphoma","volume":"26","author":"O'Malley","year":"2017","journal-title":"Ann Diagn Pathol"},{"key":"10.1038\/modpathol.2017.135_bib26","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2017.135_bib27","unstructured":"Vogt N, Dai B, Erdmann T et al. The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma 2016;1\u20138."},{"key":"10.1038\/modpathol.2017.135_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"key":"10.1038\/modpathol.2017.135_bib29","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1182\/blood-2013-02-480418","article-title":"SOX11 is a mantle cell lymphoma oncogene","volume":"121","author":"Ferrando","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.135_bib30","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/leu.2015.355","article-title":"SOX11 defines two different subtypes of mantle cell lymphoma through transcriptional regulation of BCL6","volume":"30","author":"Palomero","year":"2016","journal-title":"Leukemia"},{"key":"10.1038\/modpathol.2017.135_bib31","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1182\/blood-2012-06-438937","article-title":"SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma","volume":"121","author":"Vegliante","year":"2013","journal-title":"Blood"},{"key":"10.1038\/modpathol.2017.135_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00428-016-2016-8","article-title":"Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14","volume":"469","author":"Gallo","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1038\/modpathol.2017.135_bib33","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.anndiagpath.2014.03.006","article-title":"Progressive leukemic non-nodal mantle cell lymphoma associated with deletions of TP53, ATM, and\/or 13q14","volume":"18","author":"Chapman-Fredricks","year":"2014","journal-title":"Ann Diagn Pathol"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017135","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222012157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222012157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/modpathol.2017.135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol2017135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:48:15Z","timestamp":1760230095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222012157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0893395222012157"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2017.135","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2017.135","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}